By Colin Kellaher

 

Gilead Sciences Inc. (GILD) Tuesday said it named Andrew Dickinson chief financial officer, effective Nov. 1.

The Foster City, Calif., biopharmaceutical company said Mr. Dickinson succeeds Robin Washington, who earlier this year announced plans to retire.

Mr. Dickinson, who joined Gilead in 2016, currently serves as executive vice president of corporate development and strategy and will retain responsibility for those functions, the company said.

Gilead in April said Ms. Washington would remain in an advisory capacity through the completion of the company's reporting of its 2019 financial results early next year.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

October 15, 2019 08:56 ET (12:56 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gilead Sciences Charts.